The largest database of trusted experimental protocols

7 protocols using dynasore

1

Macrophage Differentiation and Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
Monocytes were obtained by gradient centrifugation of peripheral blood mononuclear cells (PBMCs) and cultured as described.33 At day 3, 25 ng/mL of granulocyte colony‐stimulating factor (Invitrogen Corporation, Carlsbad, CA, USA) were added, and macrophages were selected by adhesion. Medium and all reagents were endotoxin free.
Macrophage lineage characterization was based on morphological study and expression of the monocytes‐macrophages lineage marker, CD14 (see below).
To block dynamin‐dependent endocytosis,34in vitro differentiated macrophages were treated with 40 and 400 μM of dynasore (Enzo Life Sciences, Lausen, Switzerland) for 30 minutes and processed for immunoflurescence.
Cells were also treated for 1‐24 hours with 700 nM of Hepc (Peptide Institute, Minoh‐shi Osaka, Japan) and subjected to immunofluorescence.
In specific experiments, cells were preincubated for 18 hours with 0.25 µM of dexamethasone phosphate (Dx; Sigma‐Aldrich, St. Louis, MO, USA), a known stimulator of CD163 expression and hemoglobin (Hb) uptake by macrophages,35 and then incubated for 6 hours with 20 μg/mL of bovine Hb (Sigma‐Aldrich). Donor macrophages were also treated with aged red blood cells as reported.36 Cells were harvested and processed for immunofluorescence.
Cellular ferritin content and iron in the medium were assayed after overnight incubation as specified below.
+ Open protocol
+ Expand
2

Myc-Protein Phagocytosis Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
J774 cells stably expressing Myc-tagged proteins were washed in ice-cold HBSS and incubated for 30 min on ice in the presence of an ∼20-fold excess amount of IgG-opsonized latex beads incubated for 5 min at 30°C to initiate phagocytosis. The cells were washed three times in ice-cold HBSS and incubated for 20 min on ice in the presence of Alexa Fluor 647 to stain the beads outside the cells to distinguish them from engulfed beads. The cells were then washed in ice-cold HBSS and incubated in HBSS containing DMSO, dynasore (final 50 µM, Enzo Life Sciences, Farmingdale, NY), MiTMAB (final 20 µM, Sigma-Aldrich), or Pitstop 2 for the indicated times at 30°C in the presence of cytochalasin B to inhibit the formation of new phagosomes. Following incubation, the cells were washed in PBS and fixed with 100% methanol for 7 min at −20°C. Subsequently, the cells were incubated with 2% BSA/PBS for 30 min at 25°C, treated with anti-Myc and anti-LAMP1 antibodies, and stained with Alexa Fluor 488-conjugated goat antimouse and Alexa Fluor 594-conjugated goat antirat secondary antibodies (Invitrogen), respectively. Images were captured on an LSM780 microscope. More than 30 phagosomes were counted for each experiment and categorized into two types (Myc- or LAMP1-positive phagosome or unlabeled phagosome) based on the presence or absence of a detectable Alexa Fluor fluorescence signal.
+ Open protocol
+ Expand
3

Dynasore Treatment of Larval Tracheae

Check if the same lab product or an alternative is used in the 5 most similar protocols
apn1 mutant tracheae from second instar larvae were dissected in Grace’s medium supplemented with Pen/Strep. Tissues were incubated in 60μM dynasore (Enzo Life Sciences) in Grace’s medium containing Pen/Strep and 2.5% FCS at room temperature for 2hr. The dynasore was washed out and tracheae were fixed in 4% FA in Grace’s medium for 30min.
+ Open protocol
+ Expand
4

Nanoparticle Uptake Mechanisms and Intracellular Localization

Check if the same lab product or an alternative is used in the 5 most similar protocols
Poly(lactic co-glycolic acid) with a carboxyl terminus (PLGA, 50:50 monomer ratio and 0.55-0.75 dL/g inherent viscosity) was purchased from LACTEL®. The lipid, 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[carboxy(polyethylene glycol)-2000] (DSPE-PEG), used for one of the surface modifications was purchased from Avanti Polar Lipids. The following peptides were synthesized with an N-terminus cysteine or biotin, followed by a serine-glycine spacer, and were RP-HPLC purified by the W.M. Keck Peptide Synthesis Facility at Yale University (New Haven, CT):
Penetratin (AP): SG-RQIKIWFQNRRMKWKK
End binding protein 1 (EB1): SG-LIRLWSHLIHIWFQNRRLKWKKK
MPG: SG-GALFLGFLGAAGSTMGAWSQPKKKRKV
MPGΔNLS: SG-GALFLGFLGAAGSTMGAWSQPKSKRKV
For uptake inhibition studies, the following chemicals were purchased: Dynasore (Enzo Life Sciences), Chlorpromazine (Sigma), Nystatin (Sigma) and LY294002 (Cell Signaling Technology). To determine intracellular localization, the following primary antibodies were ordered from Cell Signaling Technology and used to stain intracellular proteins: EEA1 (C45B10) rabbit mAb, Rab5 (C8B1) rabbit mAb, Rab7 (D95F2) XP, clathrin heavy chain (CHC) (D3C6) XP® rabbit mAb, and Rab11 (D4F5) XP® rabbit mAb. LAMP-1, a mouse mAb, was ordered from Santa Cruz Biotechnology. Donkey anti-mouse and anti-rabbit rhodamine-conjugated secondary antibodies were purchased from Invitrogen.
+ Open protocol
+ Expand
5

Generation of CCR5-GFP Expressing U87.CD4 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following reagent was obtained through the NIH AIDS Reagent Program, Division of AIDS, NIAID, NIH: U87.CD4 from Dr. HongKui Deng and Dr. Dan R. Littman. CCR5-GFP was stably expressed in U87.CD4 cells using a lentivirus-based strategy. Briefly, packaging plasmid ΔNRF, retroviral vector pBABE.CCR5-GFP and VSV-G were cotransfected into 293T cells. After 48 hours, supernatants were harvested and used to transduce U87.CD4 cells. The polyclonal population was sorted by FACS for a low-expressing GFP cell population. The CCR5-GFP fusion product was found to remain intact after protein synthesis (Figure S1). U87.CD4.CCR5-GFP cells were maintained in DMEM (Cellgro, Manassass, VA USA) with 10% FBS and 2µg/mL puromycin (InvivoGen, San Diego, California, USA). The puromycin concentration was based on previous cytotoxicity assays. 293-Affinofile cells were maintained in DMEM supplemented with 10% FBS and 50µg/mL Blasticidin S HCl (Invitrogen, Grand Island, NY). To induce CCR5 expression, 293-Affinofile cells were treated with either 0.25µM or 1.0µM Ponasterone (Invitrogen) for 24 hours prior to experimental setup. Chlorpromazine (Sigma, St. Louis, MO, USA) and sucrose (VWR, Radnor, PA, USA) were dissolved in distilled water. Dynasore (Enzo Life Sciences, Farmingdale, NY, USA) and Nystatin (Sigma) were dissolved in DMSO.
+ Open protocol
+ Expand
6

Dynamin, Clathrin and Caveolin Inhibitors Impact Viral Transduction

Check if the same lab product or an alternative is used in the 5 most similar protocols
U343 cells were pretreated with dynamin 2 inhibitor (dynasore—40 μM, Enzo Life Sciences, Farmingdale, NY, USA), clathrin inhibitor (CPZ—5 μM, Enzo Life Sciences), or caveolin inhibitor (genistein—37 μM, Enzo Life Sciences) for 45 min, along with PBS as a negative control. Then the cells were treated with SBHA (20 μM) or MS-275 (2 μM) for 24 h, along with PBS as a negative control. Subsequently, the cells were transduced with dAd/GFP at an MOI of 50 or 100 for another 24 h. The GFP expression was analyzed and quantified using the IncuCyte® Live-Cell Analysis System (Sartorius) as described above.
+ Open protocol
+ Expand
7

Immune Stimulation Reagents Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following reagents were used in the study: highly purified LPS (LPS E. coli, Serotype O111:B4,TLRgrade™, Enzo Life Sciences, Inc., Farmingdale, NY) synthetic bacterial lipoprotein, Pam3CSK4 (TLR1/2 ligand), a synthetic diacylated lipoprotein FSL-1 (TLR2/6 ligand), all from InvivoGen (San Diego, CA); ZVAD (Z-Tyr-Val-Ala-Dl-Asp-Fluoromethylketone, Bachem Americas, Inc., Torrance, CA), Kineret (Amgen, Thousand Oaks, CA), human recombinant IL-1β (rIL-1β, Endotoxin level <0.1 ng/µg, Life Technologies, Grand Island, NY), and dynasore (Enzo).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!